Theranos’ Ghost: AI Safety & The FDA’s Billion-Dollar Blunder
The cautionary tale of Theranos, culminating in a belated FDA warning letter, offers a stark blueprint for the critical need to proactively address AI safety…
Cerebral’s 10 Million Dollar Fine: New AI Safety Standard for Telehealth
The recent dual enforcement action against Cerebral by the Department of Justice (DOJ) and the Federal Trade Commission (FTC), which included a $10 million civil…
BetterHelp Fine: Investor Warning on AI Health Data Risks
The Federal Trade Commission’s (FTC) recent $7.8 million fine against BetterHelp represents a watershed moment, not just for digital mental health platforms, but for the…
23andMe Breach: Why Genetic Data Security is Health AI’s Bedrock
The recent genetic data breach at 23andMe serves as a stark, urgent reminder for health system CIOs and patient safety advocates: in the realm of…
Meta Pixel Lawsuits: Patient Data Shared with Facebook
The intersection of digital health and patient privacy has been thrust into sharp relief by a series of lawsuits targeting hospital systems for their use…
Healthcare AI: When Cost-Bias Endangers Patients
The promise of artificial intelligence in healthcare is often framed through lenses of efficiency and precision, yet a critical, often overlooked, dimension is its potential…
Pulse Oximeter Bias: Unfixed 30-Year Flaw in AI-Driven Care
The promise of artificial intelligence in healthcare is often framed by its potential to revolutionize diagnostics, personalize treatment, and enhance patient outcomes. Yet, a critical…
Olive AI: The Billion Dollar Bust Built on Evidence-Free Hype
The narrative of AI in healthcare is often painted with broad strokes of transformative potential, promising unparalleled efficiencies and diagnostic precision. Yet, the spectacular rise…
Babylon Health’s Billion Dollar AI Bet: The Accuracy Collapse
The spectacular collapse of Babylon Health, once valued at $4.2 billion, serves as a stark reminder to investors and health system CIOs alike: the promise…
Theranos to AI: Why FDA’s Lagging Oversight Demands a Reboot
The specter of Theranos, a cautionary tale of unchecked innovation and devastating consequences, continues to loom large over the healthcare technology landscape. As artificial intelligence…